Apparatus for analyzing biological liquids
    2.
    发明授权
    Apparatus for analyzing biological liquids 失效
    用于分析生物液体的装置

    公开(公告)号:US4415534A

    公开(公告)日:1983-11-15

    申请号:US308775

    申请日:1981-10-05

    CPC classification number: G01N35/00

    Abstract: An apparatus for analyzing biological liquids comprises a measuring block including measuring means for measuring characteristics of said liquids. The measuring block is mounted within a thermal shield or housing by means of a base member interconnecting a minor part of the inner wall of the housing and the measuring block so as to define a space between the inner walls of the housing and the measuring block, said space being filled with air or another medium having a poor thermal conductivity.The thermal shield or housing and the base member are made of a material with good thermal conductivity, and heating and/or cooling means are arranged in heat conductive contact with the said shield. The function of the heating and/or cooling means is controlled by a temperature sensor arranged in heat conductive contact with the measuring block, so as to maintain the temperature of said block at a substantially constant predetermined value.

    Abstract translation: 用于分析生物液体的装置包括测量块,其包括用于测量所述液体的特性的测量装置。 测量块通过将壳体的内壁的小部分和测量块互相连接的基座构件安装在热屏蔽或壳体内,以便在壳体的内壁和测量块之间限定空间, 所述空间填充有空气或导热性差的介质。 热屏蔽或壳体和基座构件由具有良好导热性的材料制成,并且加热和/或冷却装置布置成与所述屏蔽件导热接触。 加热和/或冷却装置的功能由布置成与测量块导热接触的温度传感器控制,以便将所述块的温度保持在基本恒定的预定值。

    Method and an apparatus for determining blood components
    7.
    发明授权
    Method and an apparatus for determining blood components 失效
    用于测定血液成分的方法和装置

    公开(公告)号:US4997769A

    公开(公告)日:1991-03-05

    申请号:US512038

    申请日:1990-04-13

    CPC classification number: G01N21/31 G01N2021/3129 Y10T436/113332

    Abstract: Method and apparatus for spectrophotometrically determining the concentration of a number of hemoglobin derivatives comprising at least deoxyhemoglobin and oxyhemoglobin or parameters derived from the concentration of individual hemoglobin derivatives, in particular the oxygen saturation fraction, in whole blood, in which light is transmitted to the blood under test, the modification on the light transmitted to the blood which the blood causes is determined at a number of individual wavelengths, and the concentrations (or the derived parameters) are determined on the basis of the light modification at the individual wavelengths and on the basis of predetermined coefficients representing the light absorption characteristics of each of the hemoglobin derivatives at each of the individual wavelengths, any error on the determination values due to turbidity being substantially compensated for by utilizing predetermined coefficients representing an absorption characteristic of turbidity at each of the wavelengths. The measurement is normally performed at a number of wavelengths which is at least equal to the number of hemoglobin derivatives to be determined plus one. Although the turbidity-caused contribution to the total reduction in the light transmission is not based on any direct proportionality between the reduction in light transmission and the concentration of the turbidity-causing components (such as is the case with the hemoglobin derivatives), the "absorbances" caused by the turbidity at each particular wavelength may simply be eliminated from the equation set from which the concentrations of the hemoglobin derivatives are calculated.

    Abstract translation: 用于分光光度测定多种血红蛋白衍生物的浓度的方法和装置,所述血红蛋白衍生物至少包含脱氧血红蛋白和氧合血红蛋白或衍生自单个血红蛋白衍生物浓度的参数,特别是全血中的氧饱和度,其中光透射到血液中 在测试中,在多个单个波长处确定传输到血液引起的血液的光的变化,并且基于各个波长处的光修饰确定浓度(或导出的参数),并且在 基于表示各个波长中的每一个的每个血红蛋白衍生物的光吸收特性的预定系数的基础,通过利用表示在e处的浊度的吸收特性的预定系数来基本上补偿由浊度导致的确定值上的任何误差 ach的波长。 测量通常以至少等于要确定的血红蛋白衍生物数目加上一个的多个波长进行。 虽然对透光性的总体减少的浊度引起的贡献不是基于光透射的降低与浊度成分的浓度(例如血红蛋白衍生物的情况)之间的任何直接比例关系,但是“ 可以简单地从计算出血红蛋白衍生物的浓度的方程组中消除由每个特定波长的浊度引起的吸光度。

Patent Agency Ranking